Premarket Mover: G1 Therapeutics Inc (GTHX) Down 4.83%

Friday, October 27, 2023 06:50 AM | InvestorsObserver Analysts

Mentioned in this article

G1 Therapeutics Inc (GTHX) is lower by Friday morning, with the stock decreasing -4.83% in pre-market trading to 1.38. GTHX's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, the stock ranks higher than 3% of stocks. G1 Therapeutics Inc has risen 15.08% over the past month, closing at $1.44 on September 29. During this period of time, the stock fell as low as $1.12 and as high as $1.57. GTHX has an average analyst recommendation of Strong Buy. The company has an average price target of $11.40.

GTHX has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on GTHX!
G1 Therapeutics Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, GTHX ranks better than 131% of stocks.

Important Dates for Investors in GTHX:

-G1 Therapeutics Inc is set to release earnings on 2023-11-01. Over the last 12 months, the company has reported EPS of $-1.70. -We do not have a set dividend date for G1 Therapeutics Inc at this time. Click Here To Get The Full Report on G1 Therapeutics Inc (GTHX)

Share this article: